Government is likely to reduce generic price by 20%

The government will likely exclude drugs of low quality from the insurance-covered drug lists by reducing their prices by 20 percent in conjunction with the patent-off brands, dealing a blow to small and uncompetitive drug makers.

Healthcare experts and industrial watchers pointed out that although the National Reform Committee approved the government's plan to allow only new and cost-effect...